<b id="lnedg"><form id="lnedg"></form></b>
<cite id="lnedg"><noscript id="lnedg"><samp id="lnedg"></samp></noscript></cite><rt id="lnedg"><optgroup id="lnedg"><acronym id="lnedg"></acronym></optgroup></rt>
<b id="lnedg"></b>

    <font id="lnedg"></font>

    <rt id="lnedg"></rt>
  1. <tt id="lnedg"></tt>
    <rt id="lnedg"></rt>

    <tt id="lnedg"></tt><u id="lnedg"><tbody id="lnedg"><label id="lnedg"></label></tbody></u>

        <cite id="lnedg"></cite>
        1. Products

           Pravastatin Sodium
           Mycophenolic Acid

          Contact: Mr. Kang / Ms. Lin
          TEL:  0086-763-3865280
          FAX:  0086-763-3366526
          ADD:  Renmin One Road 
           Qingyuan Guangdong
          P.C.:  511515





          Products of APIs

          Common Name:Pravastatin Sodium

          QUALITY STANDARD:Compliant with USP, EP and JP

          CAS Registry Number:81131-70-6

          Molecular Formula:C23H35NaO7

          Molecular Mass:446.52

          Structural Formula

          Chemical  Name:(1S-(1-alpha(beta-S*,delta-S*)-2-alpha,6-alpha,8-beta(R*),8a-alpha))-1,2,6,7,8,8a-hexahydro-2-methyl-8-(2-methyl-1-oxobutoxy)-beta,delta,6-trihydroxy-1-Naphthaleneheptanoic acid monosodium salt
          Appearance: White  or off-white crystalline powder
          Therapeutic Category:Antihyperlipidemic; inhibitor (HMG - CoA reductase)
          Mechanism of action: HMG-CoA  reductase is the rate-limiting enzyme for cholesterol synthesis. Pravastatin  inhibits cholesterol synthesis by reversibly inhibiting HMG-CoA reductase.  Pravastatin functions in two aspects: (1) reduces cellular cholesterol  synthesis by reversibly inhibiting HMG-CoA reductase activity, so as to  increase low density lipoprotein (LDL) receptors, (2) inhibits the prodrug of  LDL-- very low density lipoprotein (VLDL) in liver so as to inhibit the  synthesis of LDL.
          Download the contract



          粵公網安備 44180202000306號  網站備案:粵ICP備16104045號 互聯網藥品信息服務資格證書(粵)—非經營性—2021—0443